Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 02/11 04:01:03 pm
59.52 USD   -2.55%
10:41a BRISTOL MYERS S : The 2015 Coast 2 Coast 4 Cancer Ride
02/09 BRISTOL MYERS S : Meet Biff: A Cancer Clinical Trial Patient
02/09 BRISTOL MYERS S : receives approval from US FDA for Daklinza hepatit..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Bristol Myers Squibb : Trademark Application for "BARACLUDE" Filed by Bristol-Myers Squibb

02/11/2016 | 04:35pm US/Eastern

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "BARACLUDE" by Marilyn F. Kelly, representing Bristol-Myers Squibb. This application was made available to the public on January 30, 2016 (see also Pharmaceutical Companies).

The international trademark goods and services class codes for this trademark application are 005, 016 and 041.

The serial number for this application is 78606737.

The applicant indicates that "Color is not claimed as a feature of the mark."

As submitted by the applicant, this trademark application relates to the following goods and services:

• [ Pharmaceutical preparations for human use for the treatment of infectious diseases. ];

• Printed matter, namely, brochures, lettherhead and business cards on the subject of hepatitis B;

• Educational services, namely, conducting classes, seminars, conferences or workshops in the field of hepatitis B.

The owner/registrar information for this application is: Marilyn F. Kelly, Bristol-Myers Squibb, 345 Park Avenue, NEW YORK NY 10154.

Keywords for this news article include: Trademarks, Biotechnology Companies, Biopharmaceutical Companies, Bristol-Myers Squibb Company.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC

(c) 2016 NewsRx LLC, source Health Newsletters

React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
04:35p BRISTOL MYERS SQUIBB : Trademark Application for "BARACLUDE" Filed by Bristol-My..
03:28p BRISTOL MYERS SQUIBB : Patent Issued for Co-Processing Method and Formulations f..
03:20p BRISTOL MYERS SQUIBB : Patent Issued for Methods for the Preparation of HIV Atta..
03:04p BRISTOL MYERS SQUIBB : An Application for the Trademark "APOTHECON" Has Been Fil..
02:39p BRISTOL MYERS SQUIBB : Trademark Application for "WESTWOOD SQUIBB" Filed by Bris..
01:51p BRISTOL MYERS SQUIBB : Investigators from Bristol-Myers Squibb Report New Data o..
10:41a BRISTOL MYERS SQUIBB : The 2015 Coast 2 Coast 4 Cancer Ride
02/09 BRISTOL MYERS SQUIBB : Meet Biff: A Cancer Clinical Trial Patient
02/09 BRISTOL MYERS SQUIBB : receives approval from US FDA for Daklinza hepatitis C tr..
02/08 BRISTOL MYERS SQUIBB : FDA approves expanded use of Daklinza in HCV genotypes 1 ..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials